StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $7.00 target price on shares of TRACON Pharmaceuticals in a report on Monday, […]
Related Keywords
United States , , York Mellon Corp , Renaissance Technologies , Millennium Management , Pharmaceuticals Inc , Susquehanna International Group , Ci Private Wealth , Pharmaceuticals Stock Performance , Pharmaceuticals Daily , Free Report , New York Mellon Corp , Get Free Report , Tracon Pharmaceuticals , Nasdaq Tcon , Ltcon , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.